Lexaria Bioscience Corp. Discusses Demonstration of Improved Oral Delivery for Antiviral Drugs with The Stock Day Podcast
Dec 08, 2020, 01:45 PM
The Stock Day Podcast welcomed Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX), the developer of DehydraTECH™, a proprietary drug delivery technology that improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.
READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-demonstration-of-improved-oral-delivery-for-antiviral-drugs-with-the-stock-day-podcast-lxrp-december-8-2020/
READ FULL PRESS RELEASE HERE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-demonstration-of-improved-oral-delivery-for-antiviral-drugs-with-the-stock-day-podcast-lxrp-december-8-2020/